 It's 920 here at Northwest News Radio. Your money update now from Dom Savino. Two of the world's largest drug makers are moving in opposite directions today. It's all because of a new data analysis showing Eli Lilly's popular obesity drug, Monjaro, leads to faster and greater weight loss than Novo Nordisk's treatment, Wegovii.